Metabolomics Breakthrough Advances CAR T Safety Science
MORRISVILLE, NORTH CAROLINA, UNITED STATES — February 17, 2026 Metabolon announced that its global metabolomics platform has enabled the...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
MORRISVILLE, NORTH CAROLINA, UNITED STATES — February 17, 2026 Metabolon announced that its global metabolomics platform has enabled the...
Emeryville, California, October 29, 2025 — Kyverna Therapeutics Inc. (Nasdaq: KYTX) announced positive interim Phase 2 data from the...
